SEI INVESTMENTS CO - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 128 filers reported holding ANTARES PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2021$131,0000.0%33,6190.0%0.00%
Q4 2020$131,000
+48.9%
33,619
-3.2%
0.00%
Q3 2020$88,000
-2.2%
34,742
+0.6%
0.00%
Q2 2020$90,000
+12.5%
34,534
-1.1%
0.00%
Q1 2020$80,000
-88.6%
34,924
-76.7%
0.00%
-100.0%
Q4 2019$703,000
+342.1%
149,643
+185.4%
0.00%
+100.0%
Q1 2019$159,00052,4390.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
WILLIAM HARRIS INVESTORS INC 2,338,735$6,244,0001.73%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,603,703$25,642,0001.03%
Broadfin Capital, LLC 6,100,000$16,288,0000.80%
ASHFORD CAPITAL MANAGEMENT INC 1,088,675$2,907,0000.58%
MARINER INVESTMENT GROUP LLC 296,477$792,0000.15%
THOMPSON DAVIS & CO., INC. 36,500$97,0000.14%
Peregrine Asset Advisers, Inc. 53,034$142,0000.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,165,738$3,101,0000.12%
Avenir Corp 341,035$911,0000.08%
Brown Advisory Securities, LLC 50,550$135,0000.05%
View complete list of ANTARES PHARMA INC shareholders